The company faces production risks related to the complexity of its laboratory processes and compliance with government manufacturing and storage standards. Products must be stored and transported within specified temperature ranges to preserve shelf-life, safety, and efficacy. Failure to maintain these conditions can result in inventory losses, product recalls, reputational harm, and liability risks. The FDA conducts inspections of manufacturing and contract manufacturing facilities without prior notice to evaluate compliance with current Good Manufacturing Practices (cGMP) and other regulations. Non-compliance may lead to regulatory actions such as fines, recalls, production shutdowns, or criminal prosecution, potentially impacting the company's business and financial condition. Additionally, the FDA may mandate changes to labeling, marketing claims, or suspend sales of certain products derived from human cells or tissues if they do not meet the criteria for regulation solely under Section 361 of the Public Health Service Act (PHSA).
Adia Nutrition's Comment on Supply Chain
The company faces production risks related to the complexity of its laboratory processes and compliance with government manufacturing and storage standards. Products must be stored and transported within specified temperature ranges to preserve shelf-life, safety, and efficacy. Failure to maintain these conditions can result in inventory losses, product recalls, reputational harm, and liability risks. The FDA conducts inspections of manufacturing and contract manufacturing facilities without prior notice to evaluate compliance with current Good Manufacturing Practices (cGMP) and other regulations. Non-compliance may lead to regulatory actions such as fines, recalls, production shutdowns, or criminal prosecution, potentially impacting the company's business and financial condition. Additionally, the FDA may mandate changes to labeling, marketing claims, or suspend sales of certain products derived from human cells or tissues if they do not meet the criteria for regulation solely under Section 361 of the Public Health Service Act (PHSA).
Sources:
Adia Nutrition, Inc.'s official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Adia Nutrition, Inc.’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
